热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易

客户端

　　野村发布报告称，维持百济神州（06160）“买入”评级，基于DFC估值，将目标价上调7.8%，由174.91港元升至188.53港元，认为其仍有32%的股价上升空间。野村预计百济神州2024年第4季表现强劲，2025年实现管理层指引的营运盈亏平衡。

　　野村称，由于Zanubrutinib（BTK抑制剂）销售预测上调，上调2024及2025年收入预测分别至37亿美元及47亿美元。考虑到加速折旧导致毛利率下降，上调2024年净亏损，但又因销售预估上调带来更大的规模经济效益，故下调2025年净亏损。此外，野村预计百济神州在第4季录得销售额10.22亿美元及净亏损6300万美元。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：史丽君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.